Group 1 - The stock price of Kewei Medical (301087.SZ) has dropped to 54.38 yuan, reflecting a decline of 3.32%, and the stock is currently in a state of breaking issue [1] - Kewei Medical was listed on the Shenzhen Stock Exchange's Growth Enterprise Market on October 25, 2021, with an initial public offering (IPO) of 40 million shares at a price of 93.09 yuan per share [1] - The total funds raised from the IPO amounted to 3.724 billion yuan, with a net amount of 3.527 billion yuan after deducting issuance costs, which was 2.52 billion yuan more than the original plan of 1.007 billion yuan [1] Group 2 - The total issuance costs for Kewei Medical's IPO were 197 million yuan, with underwriting and sponsorship fees accounting for 174 million yuan [2] - In the annual equity distribution announcement for 2021, Kewei Medical declared a plan to distribute 16.00 yuan in cash for every 10 shares and to increase the share capital by 3.00 shares for every 10 shares held [2] - The total share capital before the distribution was 160,375,000 shares, which increased to 208,487,500 shares after the distribution [2]